STAT
Child’s sudden death unnerves a promising area of gene therapy research
Researchers hoped they had finally found a way to get gene therapies past the blood-brain barrier. Then the first patient ...
Becker's Hospital Review
Intellia trial participant dies after severe liver reaction
Intellia Therapeutics temporarily paused dosing and screening for its phase 3 Magnitude and Magnitude-2 trials of Nex-z following a patient hospitalization, according to an Oct. 27 news release. The ...
The Boston Globe
Intellia tumbles after patient dies following Crispr treatment
Intellia Therapeutics Inc. shares dropped after the company said a patient died after suffering liver damage in a clinical trial for the company’s gene-editing treatment. The patient, who was in his ...
Heartland
FDA Halts, Then Resumes Gene Therapy After Three Deaths
After the deaths of three patients, the maker of an investigational gene therapy stopped shipments of the drug after it refused a request from the U.S. Food and Drug Administration (FDA) to pull the ...
NBC Bay Area
Baby released from Philadelphia hospital after receiving personalized gene editing therapy
After spending over 300 days at the Children's Hospital of Philadelphia (CHOP), 9-month-old KJ Muldoon has been released from the hospital after receiving personalized CRISPR gene editing therapy.
Science Daily
Gene-edited CAR-T cells erase aggressive T-cell leukemia
A cutting-edge therapy using base-edited immune cells is offering a major breakthrough for patients with one of the toughest ...